Radial Extracorporeal Shock Wave Therapy as a Novel Agent for Benign Prostatic Hyperplasia Refractory to Current Medical Therapy

This study aimed to assess efficacy and safety data from pilot trials of the radial extracorporeal shock wave therapy (rESWT) to treat benign prostatic hyperplasia (BPH) refractory to current medical therapy. A total of 29 men with lower urinary tract symptoms (LUTS) suggestive of BPH who had respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Dai, Wang, Yun-Lei, Gong, Da-Xin, Zhang, Zhao-Xuan, Yu, Xiao-Tong, Ma, Yue-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440046/
https://www.ncbi.nlm.nih.gov/pubmed/30767611
http://dx.doi.org/10.1177/1557988319831899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440046/
https://www.ncbi.nlm.nih.gov/pubmed/30767611
http://dx.doi.org/10.1177/1557988319831899

Ejemplares similares